|
Exchange Disseminated Time 02/05/2018 11:02:13 | Caplin Point Laboratories Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on May 28, 2018, inter alia:
1. To consider and approve the Audited Financial Results for quarter/ year ended March 31, 2018.
2. Recommendation of Dividend for the financial year 2017-18.
Accordingly, the Trading Window for dealing in the equity shares of the Company will remain closed for Promoters, Directors, other Connected Persons and Employees of the Company from May 03, 2018 to May 30, 2018 (both days inclusive) as per the Company's Code of Conduct to regulate, monitor and report trading by insiders adopted by the Board pursuant to SEBI(Prohibition of Insider Trading) Regulations, 2015. |
|
|